Literature DB >> 31237488

The Traceability of Mesenchymal Stromal Cells After Injection Into Degenerated Discs in Patients with Low Back Pain.

Helena Barreto Henriksson1,2,3, Nikolaos Papadimitriou1,4, Daphne Hingert1, Adad Baranto1,4, Anders Lindahl3, Helena Brisby1,4.   

Abstract

Low back pain is a major health issue and one main cause to this condition is believed to be intervertebral disc (IVD) degeneration. Stem cell therapy for degenerated discs using mesenchymal stromal cells (MSCs) has been suggested. The aim of the study was to investigate the presence and distribution pattern of autologous MSCs transplanted into degenerated IVDs in patients and explanted posttransplantation. IVD tissues from four patients (41, 45, 47, and 47 years of age) participating in a clinical feasibility study on MSC transplantation to degenerative discs were investigated. Three patients decided to undergo fusion surgery at time points 8 months and one patient at 28 months posttransplantation. Pretransplantation, MSCs from bone marrow aspirate were isolated by centrifugation in FICOLL® test tubes and cultured (passage 1). Before transplantation, MSCs were labeled with 1 mg/mL iron sucrose (Venofer®) and 1 × 106 MSCs were transplanted into degenerated IVDs. At the time point of surgery, IVD tissues were collected. IVD tissue samples were fixated, embedded in paraffin, and sections prepared. IVD samples were stained with Prussian Blue, by which iron deposits are visualized and examined (light microscopy). Immunohistochemistry (IHC), including SOX9 (sex determining region Y box 9), Coll2A1 (collagen 2A1), and cell viability (TUNEL) were performed. Cells positive for iron deposits were observed in IVD tissues (3/4 patients). The cells/iron deposits were observed in clusters and/or as solitary cells in regions in IVD tissue samples [regions of interest (ROIs)]. By IHC, SOX9- and Coll2A1-positive cells were detected in the same regions as the detected cells/iron deposits. A few nonviable cells were detected by TUNEL assay in ROIs. Results demonstrated that MSCs, labeled with iron sucrose, transplanted into degenerated IVDs were detectable 8 months posttransplantation. The detected cellular activity indicates that MSCs have differentiated into chondrocyte-like cells and that the injected MSCs and/or their progeny have survived since the cells were found in large cluster and as solitary cells which were distributed at different parts of the IVD.

Entities:  

Keywords:  cell therapy cell tracer; chondrogenic differentiation; disc degeneration; intervertebral disc; iron sucrose labeling; mesenchymal stem cells

Year:  2019        PMID: 31237488     DOI: 10.1089/scd.2019.0074

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  11 in total

Review 1.  Stem cell-based therapy for human diseases.

Authors:  Duc M Hoang; Phuong T Pham; Trung Q Bach; Anh T L Ngo; Quyen T Nguyen; Trang T K Phan; Giang H Nguyen; Phuong T T Le; Van T Hoang; Nicholas R Forsyth; Michael Heke; Liem Thanh Nguyen
Journal:  Signal Transduct Target Ther       Date:  2022-08-06

2.  Intradiscal Injection of Iron-Labeled Autologous Mesenchymal Stromal Cells in Patients With Chronic Low Back Pain: A Feasibility Study With 2 Years Follow-Up.

Authors:  Nikolaos Papadimitriou; Hanna Hebelka; Daphne Hingert; Adad Baranto; Helena Barreto Henriksson; Anders Lindahl; Helena Brisby
Journal:  Int J Spine Surg       Date:  2021-12

3.  Using iron sucrose-labeled adipose-derived mesenchymal stem cells in 1.5 and 3 T MRI tracking: An in vitro study.

Authors:  Paween Tangchitphisut; Narongrit Srikaew; Sith Phongkitkarun; Suphaneewan Jaovisidha; Tulyapruek Tawonsawatruk
Journal:  Heliyon       Date:  2020-08-01

Review 4.  Clinical Development of Regenerative Medicine Targeted for Intervertebral Disc Disease.

Authors:  Daisuke Sakai; Jordy Schol; Masahiko Watanabe
Journal:  Medicina (Kaunas)       Date:  2022-02-10       Impact factor: 2.430

5.  The preconditioning of lithium promotes mesenchymal stem cell-based therapy for the degenerated intervertebral disc via upregulating cellular ROS.

Authors:  Zemin Zhu; Hongyuan Xing; Ruofu Tang; Shengjun Qian; Shaoqi He; Qiang Hu; Ning Zhang
Journal:  Stem Cell Res Ther       Date:  2021-04-14       Impact factor: 6.832

Review 6.  Application of stem cells in the repair of intervertebral disc degeneration.

Authors:  Wentao Zhang; Tianze Sun; Ying Li; Ming Yang; Yantao Zhao; Jing Liu; Zhonghai Li
Journal:  Stem Cell Res Ther       Date:  2022-02-11       Impact factor: 6.832

Review 7.  The role of microenvironment in stem cell-based regeneration of intervertebral disc.

Authors:  Genglei Chu; Weidong Zhang; Feng Han; Kexin Li; Chengyuan Liu; Qiang Wei; Huan Wang; Yijie Liu; Fengxuan Han; Bin Li
Journal:  Front Bioeng Biotechnol       Date:  2022-08-09

Review 8.  Intervertebral Disk Degeneration: The Microenvironment and Tissue Engineering Strategies.

Authors:  Yiming Dou; Xun Sun; Xinlong Ma; Xin Zhao; Qiang Yang
Journal:  Front Bioeng Biotechnol       Date:  2021-07-20

Review 9.  Iron Oxide Nanoparticles in Mesenchymal Stem Cell Detection and Therapy.

Authors:  Kosha J Mehta
Journal:  Stem Cell Rev Rep       Date:  2022-02-01       Impact factor: 6.692

10.  Grand Challenges in Musculoskeletal Pain Research: Chronicity, Comorbidity, Immune Regulation, Sex Differences, Diagnosis, and Treatment Opportunities.

Authors:  Ke Ren
Journal:  Front Pain Res (Lausanne)       Date:  2020-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.